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Abstract
Background: Out-of-pocket payments make up about 80% of medical care spending at hospitals in Laos, thereby
putting poor households at risk of catastrophic health expenditure. Social security schemes in the form of
community-based health insurance and health equity funds have been introduced in some parts of the country.
Drug and Therapeutics Committees (DTCs) have been established to ensure rational use of drugs and improve
quality of care. The objective was to assess the appropriateness and expenditure for treatment for poor patients by
health care providers at hospitals in three selected provinces of Laos and to explore associated factors.
Methods: Cross-sectional study using four tracer conditions. Structured interviews with 828 in-patients at twelve
provincial and district hospitals on the subject of insurance protection, income and expenditures for treatment,
including informal payment. Evaluation of each patient’s medical record for appropriateness of drug use using a
checklist of treatment guidelines (maximum score = 10).
Results: No significant difference in appropriateness of care for patients at different income levels, but higher
expenditures for patients with the highest income level. The score for appropriate drug use in insured patients was
significantly higher than uninsured patients (5.9 vs. 4.9), and the length of stay in days significantly shorter (2.7 vs.
3.7). Insured patients paid significantly less than uninsured patients, both for medicines (USD 14.8 vs. 43.9) and
diagnostic tests (USD 5.9 vs. 9.2). On the contrary the score for appropriateness of drug use in patients making
informal payments was significantly lower than patients not making informal payments (3.5 vs. 5.1), and the length
of stay significantly longer (6.8 vs. 3.2), while expenditures were significantly higher both for medicines (USD 124.5
vs. 28.8) and diagnostic tests (USD 14.1 vs. 7.7).
Conclusions: The lower expenditure for insured patients can help reduce the number of households experiencing
catastrophic health expenditure. The positive effects of insurance schemes on expenditure and appropriate use of
medicines may be associated with the long-term effects of promoting rational use of drugs, including support to
active DTC work.
Background
Doctors’ prescribing practices have considerable bearing
on the effectiveness of health care treatments. There are
many factors influencing prescribing, e.g., existing laws
and regulations, types of patients, different insurance
schemes, informal payment, drug promotion, medical
product representatives and other incentives [1-5].
Therefore, questions concerning appropriateness of
treatment are of interest among health care profes-
sionals, policy-makers, administrators and researchers.
Informal payment, i.e. patients’ decision to pay extra to
the health care provider, in money or in kind, has been
listed as one problem in many health systems [6,7].
In Lao People’s Democratic Republic (Laos) the func-
tioning of health services in hospitals at different levels
has improved gradually over the last ten years, especially
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Therapeutic Committees (DTC), and standard treatment
guidelines (STGs) to develop quality of care have been
established at all provincial and district hospitals, includ-
ing remote and rural areas [10].
Four main types of insurance schemes are currently
being piloted in selected provinces in Laos: (1) the social
security system covering civil servants (CSS), (2) health
insurance schemes for the private sector (SSO), (3) com-
munity-based health insurance schemes (CBHI), and (4)
health equity funds (HEF) for the poor. The payment
under CSS is the responsibility of the government,
whereas the SSO is paid by the private companies, and
CBHI gets contributions directly from the households.
The Swiss Red Cross has supported HEF in Vientiane
province and Namebak district in Luangprabang pro-
vince. For all schemes, payments to contracted hospitals
are on a capitation basis and limited to a defined set of
services, with the exception of HEF.
An exemption policy for poor people was launched in
Laos in 1995, but has not been effective due to a limited
government budget and an unclear definition of the
term “poor people”. About 60% of health care expendi-
tures come from individuals’ own pockets [8]. Increasing
out-of-pocket expenditures in public and private health
care services are driving many families into poverty, and
are further burdening those who are already poor [11].
In addition, in order to gain access to public hospitals
and to receive a higher quality of services, in some
countries, informal payments are widespread and a
major source of inequity and inefficiency in health care
systems [6,7].
Poverty and illness constitute a vicious circle, espe-
cially in low- and middle-income countries [12], includ-
ing Laos. Low quality of services and inappropriate
practices of health providers, especially in contact with
poor patients, may result in ineffective health care,
unnecessary expenditure and a negative impact on
patients’ health and finances. Many studies on public
health facility services have been carried out in Laos,
however no study has been performed on provider
behaviour in relation to poverty and illness.
The main objectives of this study were: 1) to assess
the appropriateness of treatment by health care provi-
ders in the encounter (a) with poor patients, (b) patients
with and without insurance; 2) to determine the expen-
diture for treatment of different types of patients; and 3)
to assess factors associated with provider performance.
Methods
Study setting
This cross-sectional study was conducted in hospitals in
three provinces in the north, middle and south of Laos,
Luangprabang, Vientiane and Savannakhet, where
different insurance schemes have recently been piloted.
T h r e ed i s t r i c t si ne a c hp r o v i n c ew e r ep u r p o s i v e l y
selected to include districts where one or two of the
available security systems, CBHI and HEF, had been
introduced: Namebak, Ngoy and Xiengngeuane districts
in the Lauangprabang province; Vangvieng, Phone Hong
and Xanakham in the Vientiane province; and Cham-
phone, Outhoumphone and Sepone in the Savannakhet
province.
Sample size and sampling procedures
The provincial hospital and the three district hospitals
in each province were included - a total of 12 public
health facilities. One of the district hospitals in each
province was involved in the insurance scheme pilot,
while the other two operated without any insurance
scheme. Four tracer conditions were used for data col-
lection: a) major injury (including bone fracture), b)
hypertension, c) post-delivery haemorrhage or Caesarean
section, and d) pneumonia in children under five.
Patients were selected consecutively according to the
time of their admission to the hospital. The aim was to
recruit 20 patients per disease and per health facility,
but in spite of a period of five months for data collec-
tion we could only include a total of 828 patients.
Data collection methods
Data were collected through structured interviews with
in-patients on the surgical, medicine, obstetric and pae-
diatric wards. Data from the same patients’ medical
records were also collected. For patients with hyperten-
sion, data were mostly collected in out-patient wards.
The interviews with patients used a structured ques-
tionnaire specifically developed for the purpose of this
study. The questionnaire was pretested and modified
before use. The questions covered reasons for choosing
the facility, opinion about the service received and the
quality of care, information about service fees, including
informal payment, general satisfaction and expectations,
and recommendations for better health services. The
questionnaire was not finalised until the day of dis-
charge to ensure that all expenditure were recorded.
Demographic data and information about household
income were also collected via the questionnaire.
Information about the use of medicines and diagnostic
tests was retrieved from the patient records, including
the expenditure for medicines and diagnostic tests, fees
and other expenditure. The expenditure for prescribed
medicines and diagnostic tests were based on the price
lists compiled by the pharmacy unit at each hospital.
Fees were usually quite small and relate to charges for
consultation and documents. Other expenditure refer to
all other expenditure for the treatment episode, includ-
ing cost for equipment, transportation, accommodation
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questions on informal payment addressed whether the
patients had contributed any additional payment or
donated food or gifts of any kind to any of the health
care providers.
The appropriateness of use of medicines was assessed
by using a checklist and a scoring system, which was
based on treatment guidelines used in the hospitals for
the four tracers. Correct use of medicines according to
the guidelines, including intravenous fluids and blood
transfusions, received a positive score, while inappropri-
ate medications received negative scores. The maximum
score was 10 for all tracers.
Household income was classified into three levels
related to the specific poverty line measurement of 100
000 LAK (11 USD) per individual per month, as indi-
cated in the Lao Expenditure and Consumption Survey
(LECS II). This amount corresponds to the money
required to purchase 2 100 calories of food per person
per day, plus a non-food allowance [13,14].
Data were collected from October 2007 to March
2008 by trained data collectors with the supervision of
the principal investigator (LS) and the research team,
which visited all hospitals.
Data analysis
The standard for each tracer condition and the corre-
sponding checklists were developed by specialists from
the main central hospital, and used for evaluation of the
appropriateness of treatment and use of medicines.
E p ii n f ov e r s i o n6 . 4a n dS t a t a1 0w e r eu s e df o rd a t a
input and analysis. Frequencies, cross-tabulations, means
and standard deviation have been performed. P-value
was used to compare the prescribers’ performance
between different types of patients. Multiple linear
regression analysis was performed to identify factors
influencing higher expenditure for treatment.
Ethical clearance was obtained from the National
Ethical Committee for Health Research, Ministry of
Health, Laos. All participants were informed about the
study purpose and gave verbal consent after explanation
that all collected information would be handled
anonymously.
Results
There were in total 828 in-patients (45% women) in the
three provinces. Of these, 201 had suffered a major
injury (7 were insured), 203 had hypertension (63
insured), 201 had suffered a post-delivery haemorrhage
or had undergone a Caesarean section (25 insured) and
223 were children under five with pneumonia (21
insured). The average income per family member per
month was LAK150 000 (US$18), ranging from LAK 4
0 0 0t oL A K40 0 00 0 0( T a b l e1 ) .T h ed e m o g r a p h i c
characteristics are in concordance with information
gathered from national surveys [14].
The score for appropriate drug use was significantly
higher for insured patients than patients without insur-
ance. Insured patients received significantly fewer medi-
cines in total and also fewer antibiotics compared with
uninsured patients. Insured patients also stayed fewer
days in hospital and paid significantly less for medicines
and diagnostic tests than uninsured patients (Table 2).
There were no differences regarding quality of treat-
ment for patients at different income levels as measured
through the scores for appropriate drug use (5.0, 4.8
and 4.8, for low-, medium- and high-level income
respectively, p = 0.71). Furthermore, there were no sig-
nificant differences in how patients with different levels
of income were treated regarding use of medicines, for
example, average number of antibiotic injections (0.87,
0.93 and 0.94 for low-, medium- and high-level income
respectively, p = 0.63), and total cost of medicines (LAK
319 645, 324 685, and 370 855 respectively, p = 0.85).
H o w e v e r ,t h e r ew a sas i g n i f i c a n td i f f e r e n c er e g a r d i n g
fees, where patients in the high-level income group paid
about three times more than the two other income
groups (p < 0.0001).
Table 1 Patients background and characteristics
Description Frequency
N = 828
%
Tracer conditions
1. Major injury or bone fracture 201 24
2. Hypertension 203 25
3. Post-delivery haemorrhage or Caesarean section 201 24
4. Pneumonia in children under five 223 27
Sex
Female 375 45
Male 453 55
Professions
1. Farmer 258 31
2. Civil servant 359 43
3. Private sector employee 124 15
4. Student 52 6.3
5. Others 27 3.3
Education
0. None 146 18
1. Primary school 266 32
2. Lower-secondary school 205 25
3. Upper-secondary school 174 21
4. University 15 1.8
Income/month
Median (min-max) 150 000 (4 000-4
000 000)
Income level 1: ≤100 000 LAK 291 36
Income level 2:101 000-200 000 LAK 217 27
Income level 3: ≥201 000 LAK 310 38
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cines was significantly lower for patients with major
injury and post-delivery haemorrhage or a Caesarean sec-
tion (3.7 and 3.8, respectively), than for patients with
hypertension (5.8) and for children with pneumonia (7.1)
(p < 0.0001). The low score for patients with major injury
and post-partum treatment were mainly due to incorrect
choice of intravenous fluids and inappropriate use of oral
a n t i b i o t i c s .T h ea v e r a g eu s eo fa n t i b i o t i ci n j e c t i o nw a s
1.0 in patients with major injury, 1.5 in patients with
post-delivery haemorrhage or a Caesarean section, 0.04
in hypertensive patients, and 1.1 in children under five
with pneumonia, which for all tracers mostly corre-
sponded with recommendations in the guidelines. The
cost for patients with major injury and post-delivery hae-
morrhage or Caesarean section was significantly higher
than for the other two conditions (p < 0.0001).
Patients who made informal payments had a significantly
lower score for appropriate use of medicines than those
not making informal payments (Table 3). The prescribing
of medicines and the number of days in hospital were sig-
nificantly higher for patients making informal payments
than for those not making informal payments, and they
had to pay significantly more for medicines and diagnostic
tests than those not making informal payments. The pro-
portion of patients who paid informally was 18%, 16% and
8.9% for the high, middle and low level of incomes respec-
tively. Only nine out of the total of 110 patients with infor-
mal payment were covered by insurance. The informal
payment was mostly in cash (82%) and to a lesser extent in
kind (18%), e.g., fruit, soft drinks and meals.
The score for appropriate use of medicines was signifi-
cantly higher at district hospitals than at provincial hos-
pitals (5.3 vs. 4.8, p = 0.01). The use of medicines for
patients at provincial level was also significantly higher
than for patients at district level in terms of average
number of medicines prescribed (6.8 vs. 4.5, p < 0.0001),
number of antibiotics injections (1.3 vs. 0.7, p <0 . 0 0 0 1 )
and number of essential medicines (5.7 vs.3.9, p <
0.0001), as well as number of days in hospital (6.6 vs.1.7,
p < 0.0001). Furthermore, the patients’ expenditure for
medicines (LAK 740 350 vs. 113 100, p < 0.0001) and
diagnostic tests (LAK 95 478 vs. 47 023, p < 0.0001) was
significantly higher at provincial level although the same
tracer conditions were used at both levels.
T h e r ew e r ea l s os o m ed i f f e r e n c e sb e t w e e nt h ep r o -
vinces. Patients in Vientiane province received signifi-
cantly fewer medicines (4.2 vs. 5.7 and 5.8, p < 0.0001)
and antibiotics injections (0.5 vs. 1.1 and 1.3, p <
0.0001), and fewer diagnostic tests (0.4 vs. 1.3 and 1.9, p
< 0.0001) than patients in the two other provinces.
Patients in Savannakhet province stayed longer in hospi-
tal (8.9 vs. 3.8 and 0.8, p < 0.0001) than in the two
other provinces and they also spent more on medicines
(LAK 1 218 000 vs. 316 322 and 109 800, p < 0.0001),
diagnostic tests (LAK 120 782 vs. 57 838 and 77 071, p
= 0.009) and non-medical expenditures (LAK 730 471
vs. 131 540 and 110 129, p < 0.0001).
A higher total cost for medicines and diagnostic tests was
associated with uninsured patients, patients with higher
education, patients making informal payments, patients
treated in a provincial hospital and patients in the lowest
income-level group (Table 4). There was no association
found with sex, profession and distance from health facility.
Discussion
Prescribing practices were significantly more appropriate
for insured patients, and for patients not making
Table 2 Use of medicines, diagnostic tests and costs in LAK* for uninsured and insured patients
Description Insurance
Mean (SD)
p-value
No
N = 712
Yes
N=116
Appropriate drug use score 4.9(2.7) 5.9(2.7) 0.0001
Total number of medicines during hospital stay 5.4(2.5) 5.2(3.2) 0.04
- Number of antibiotic injections 0.98(0.89) 0.52(0.86) < 0.0001
- Number of oral antibiotics 0.49(0.58) 0.37(0.68) 0.011
- Number of essential medicines 4.6(2.1) 4.6(2.6) 0.14
- Number of brand drugs 1.3(1.4) 1.2(1.3) 0.54
Average duration of stay (days) 3.7(4.4) 2.7(3.3) 0.002
Cost of medicines (in LAK) 373 060 (772 660) 126 063 (267 340) 0.001
Cost of diagnostic tests (in LAK) 77 826 (123 104) 50 146
(54 929)
0.02
Other costs (in LAK) 360 608 (563 086) 240 745 (394 973) 0.11
Fee charge (in LAK) 53 308 (105 995) 43 166
(89 158)
0.74
* LAK = Lao KIP; 1 USD = 8 500 LAK
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cines and diagnostic tests was as well significantly lower
for insured patients and for patients not making infor-
mal payments. However, there was no difference
between poor and better-off patients. Factors associated
with the cost of medicines and diagnostic tests, which
may have influenced prescribing and treatment prac-
tices, were insurance schemes, education, low-income
level patients, level of health facility, and informal
payment.
Insured patients received significantly more appropri-
ate medicines and diagnostic tests than those without
insurance. The different insurance schemes in Laos
apply their own lists of medicines, but mostly follow the
National Essential Medicine List with generic names.
Providers were encouraged to treat insured patients
according to the list and the insured patients also
received fewer drugs, fewer antibiotics, fewer injections
in total and the expenditure were lower. Uninsured
patients, on the other hand, could receive medicines at
the prescriber’s discretion and according to the patient’s
own demands. These different preconditions seem to
h a v eh a da ni m p a c to nt h ed o c t o r s ’ prescribing habits.
A study in China showed that insured patients instead
received more antibiotics and injections than needed
possibly because prescribers received a bonus from
pharmacies from over-prescribing, and because the
income of health workers was directly related to the
drugs they sold [3,15], which is not the case for insured
patients in Laos. Studies in other countries have also
Table 3 Use of medicines, diagnostic test and cost for patients who made and did not make informal payment
respectively
Descriptions Means (SD) p-value
No informal payment
N = 674
Informal payment
N = 110
Appropriate drug use score 5.1(2.7) 3.5(2.7) <0.0001
Total number of medicines prescribed 5.3(2.6) 6.7(2.2) <0.0001
- Number of antibiotic injections 0.80(0.88) 1.4(0.89) <0.0001
- Number of oral antibiotics 0.49(0.61) 0.30(0.46) 0.001
- Number of essential medicines 4.6(2.2) 5.4(1.9) <0.0001
- Number of brand drugs 1.3(1.4) 1.4(1.7) 0.78
Average duration of stay (days) 3.2(3.9) 6.8(5.6) <0.0001
Total diagnostic test 1.2(1.5) 2.2(1.3) <0.0001
Cost of medicines 245 087
(560 887)
1 058 000 (1 236 000) <0.0001
Cost of diagnostic test 65 117
(103 274)
119 906 (162 750) <0.0001
Other costs 285 518
(497 730)
688 615 (678 346) <0.0001
Fee charge 52 255
(102 529)
69 731 (130 124) 0.52
Table 4 Suggested factors influencing provider performance in terms of total cost for medicines and diagnostic tests
in LAK*, multiple linear regression analysis (R-squared = 0.29)
Suggested factors beta coefficient Standard deviation p-value 95% confidence limits
Sex
0 = female, 1 = male
-58 571 50 455 0.246 (-157 625; 40 482)
Education
0 = low, 1 = high
117 142 59 380 0.049 (568; 233 715)
Income
0 = low, 1 = high
-139 999 52 653 0.008 (-243 366; -36 632)
Hospital level
0 = provincial, 1 = district
-578 531 52 880 <0.001 (-682 344; -474 717)
Insurance
0 = no insurance,
1 = insurance
-178 853 71 359 0.012 (-318 943; -38 763)
Informal payment
0 = no informal payment
1 = with informal payment
681 790 74 142 <0.001 (536 236; - 827 344)
* LAK = Lao Kip; 1 USD = 8 500 LAK.
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consumers [2,4,5].
Although the use of antibiotics was less for insured
patients and patients not making informal payments,
than for uninsured patients and those making informal
payments, on average, each patient still received at least
one antibiotic, except for patients with hypertension.
This was regarded as appropriate in many cases as chil-
dren with pneumonia and patients with wound injuries
should be treated with antibiotics. Appropriate use of
antibiotics is important to avoid antibiotic resistance, as
bacteria resistance is currently on the increase world-
wide, while the development of new antibiotic develop-
ment is in decline [16,17]. In a three-country compari-
son, the level of microbial resistance was highest in
C h i n a ,f o l l o w e db yK u w a i ta n dt h eU n i t e dS t a t e s[ 1 8 ] .
Other studies in China have shown that antibiotic pre-
scribing and use was connected with the interaction
between physicians and patients [15,19]. A study in
Pakistan and other studies have also demonstrated irra-
tional prescribing of injections and antibiotics [3,20,21].
Patients with major injury or bone fracture and post-
delivery haemorrhage or a Caesarean section received
less appropriate overall treatment than patients with
hypertension or pneumonia. We cannot fully explain the
reasons for this discrepancy, but it may partly be related
to the diversity of conditions covered by the guidelines
for non-infectious emergency cases.
We found that patients with a lower income level
received similar treatment as the middle- and higher-
level income groups, although patients in the highest
income-level group had higher total expenditure. In
each hospital, an exemption policy was principally
implemented: if patients could not pay, they were first
allowed credit, and then their debts were cancelled if it
t u r n e do u tt h a tt h e yr e a l l yw e r eu n a b l et op a y .I nL a o s ,
rational use of medicines has been promoted for over
fifteen years and Drug and Therapeutic Committees
have been established and function at all provincial and
several district hospitals [9,10]. Therefore, patients
should get the same treatment regardless of level of
income, which is consistent with our findings and simi-
lar to other studies, where it has been shown that provi-
ders generally have a positive attitude towards deprived
patients [22].
Patients making informal payments, who were also
mostly non-insured, received inappropriate treatment, to
a higher extent than patients not making informal pay-
ments. One possible reason could be that prescribers
tried to satisfy explicit or assumed demands from non-
insured patients by over-prescribing or choosing famous
brand name drugs at a substantially higher cost to the
patient. A study in Russia showed that in total around
15% of respondents had made informal payments in the
past three years, although it was even more common in
poorer regions. The reason for payment was said to be
to ensure access to high quality, publicly funded health
care services [6]. In a study in Greece, 36% of the total
number of those reporting treatment at public hospitals
reported at least one informal payment to a doctor. The
reasons for payment included a fear of receiving sub-
standard care, an attempt to shorten waiting time and
in some cases because the doctor had demanded such a
payment [7].
Patients at district hospitals spent less money on treat-
ment than those at provincial hospitals for the same tra-
cer conditions. The explanation could be that health
staff at district level provided less advanced care,
although the appropriateness of the care was signifi-
cantly higher. However, even if the condition is classi-
fied within the same tracer, the cases at the provincial
hospitals may have been more severe.
Study limitations included the much lower number of
insured than uninsured patients due to the recent,
incomplete introduction of insurance schemes. For the
sake of comparison, it would have been an advantage to
have more equal groups. The income level reported by
the patients may not be appropriate, which may affect
the comparisons between groups of patients with differ-
ent income levels.
Conclusions
Use of medicines and cost of care at hospitals in Laos
were more appropriate for insured patients regardless of
level of income. The lower cost for insured patients can
help reduce the number of households experiencing cat-
astrophic health expenditure. The positive effects of
insurance schemes on expenditure and appropriate use
of medicines may be associated with long-term effects
of promoting rational use of drugs, including support to
active DTC work. The Government should continue to
support the scaling-up and strengthening of social
security schemes and to implement a policy to prohibit
informal payment. Factors related to higher cost and
lower quality of care for patients who make informal
payments should be further explored.
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